catalog number :
MBS692085
products type :
Recombinant Protein
products full name :
Human IGF-BP2
products short name :
[IGF-BP2]
products name syn :
[Recombinant Human IGF-BP-2]
other names :
[insulin-like growth factor-binding protein 2; Insulin-like growth factor-binding protein 2; insulin-like growth factor-binding protein 2; IBP-2; IGFBP-2; IGF-binding protein 2; insulin-like growth factor binding protein 2, 36kDa]
products gene name :
[IGF-BP2]
other gene names :
[IGFBP2; IGFBP2; IBP2; IGF-BP53; BP2; IBP2; IBP-2; IGF-binding protein 2; IGFBP-2]
uniprot entry name :
IBP2_HUMAN
sequence :
EVLFRCPPCT PERLAACGPP PVAPPAAVAA VAGGARMPCA ELVREP GCGC CSVCARLEGE ACQVYTPRCG QGLRCYPHPG SELPLQALVM G EGTCEKRRD AEYGASPEQV ADNGDDHSEG GLVENHVDST MNMLGGG GSA GRKPLKSGMK ELAVFREKVT EQHRQMGKGG KHHLGLEEPK KL RPPPARTP CQQELDQVLE RISTMRLPDE RGPLEHLYSL HIPNCDKH GL YNLKQCKMSL NGQRGECWCV NPNTGKLIQG APTIRGDPEC HLF YNEQQEA RGVHTQRMQ
purity :
> 98% by SDS-PAGE & HPLC analyses
storage stability :
The lyophilized protein is stable at room temperature for 1 month and at 4 degree C for 6 months. Reconstituted working aliquots are stable for 1 week at 2 degree C to 8 degree C and for 3 months at -20 degree C to -80 degree C. Avoid repeated freeze and thaw cycles.
other info1 :
Endotoxin Level: < 0.1 ng/ug of protein (1<1EU/ug).
other info2 :
Biological Activity: Determined by its ability to inhibit IGF-I induced proliferation of FDC-P1 cells. Reconstitution: Centrifuge the vial prior to opening. Reconstitute in water to a concentration of 0.1-1.0 mg/m. Do not vortex. This solution can be stored at 2-8 degree C for up to 1 week. For extended storage, it is recommended to further dilute in a buffer containing a carrier protein (example 0.1% BSA) and store in working aliquots at -20 degree to -80 degree C.
products categories :
Cytokines & Growth Factors
products description :
IGF-BPs controls the distribution, function and activity of IGFs in various cell tissues and body fluids. Currently there are seven named IGF-BPs that form high affinity complexes with both IGF-I and IGF-II. IGF-BP2 is a cysteine-rich secreted protein produced by bone cells, and is most abundant in the brain. IGF-BP2 has been shown to inhibit IGF-II action in human breast and ovarian carcinoma cells. Recombinant human IGF-BP2 is a 31.5 kDa protein consisting of 289 amino acid residues including the IGF-BP domain and thyroglobulin type-I domain.
ncbi acc num :
NP_000588.2
ncbi gb acc num :
NM_000597.2
ncbi mol weight :
31.5 kDa
ncbi pathways :
Metabolism Of Proteins Pathway (106230); Myometrial Relaxation And Contraction Pathways (198759); Regulation Of Insulin-like Growth Factor (IGF) Transport And Uptake By Insulin-like Growth Factor Binding Proteins (IGFBPs) Pathway (105908)
uniprot summary :
Function: Inhibits IGF-mediated growth and developmental rates. IGF-binding proteins prolong the half-life of the IGFs and have been shown to either inhibit or stimulate the growth promoting effects of the IGFs on cell culture. They alter the interaction of IGFs with their cell surface receptors. Ref.11. Subunit structure: Binds IGF2 more than IGF1. Subcellular location: Secreted. Domain: The C-terminus is required for IGF-binding and growth inhibition. Ref.11. Post-translational modification: O-glycosylated. Ref.10. Sequence similarities: Contains 1 IGFBP N-terminal domain.Contains 1 thyroglobulin type-1 domain.